Effect of Celecoxib Combined With Low‐Dose‐Rate Brachytherapy on Long‐Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open‐Label Controlled Randomized Trial

Authors

Institutions

Publication Details

Journal
The Prostate
Published
2026-01-22
DOI
https://doi.org/10.1002/pros.70136
Primary Topic
Inflammatory mediators and NSAID effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of Celecoxib Combined With Low‐Dose‐Rate Brachytherapy on Long‐Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open‐Label Controlled Randomized Trial

Fumiaki Isohashi, Nobumichi Tanaka, Yasushi Nakai, Isao Asakawa et al.
The Prostate
Inflammatory mediators and NSAID effects
article

Effect of Celecoxib Combined With Low‐Dose‐Rate Brachytherapy on Long‐Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open‐Label Controlled Randomized Trial

Fumiaki Isohashi, Nobumichi Tanaka, Yasushi Nakai, Isao Asakawa, Kenta Onishi, Kiyohide Fujimoto, Makito Miyake, Kaori Yamaki
article en

Abstract

No abstract available for this paper.
The Prostate
Nara Medical University (JP)
Openalex Percentile: Top 78%
Inflammatory mediators and NSAID effects
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.